This is a summary of the European public assessment report (EPAR) for Duloxetine Zentiva. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Duloxetine Zentiva. For practical information about using Duloxetine Zentiva, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Treatment depressive disorder, diabetic neuropathic pain, anxiety disorder. Duloxetine Zentiva is indicated in adults.
Therapeutic Area (MeSH)
ATC Code
N06AX21
ATC Item
duloxetine
Pharmacotherapeutic Group
Other antidepressants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| duloxetine | N/A | 度洛西汀 |
EMA Name
Duloxetine Zentiva
Medicine Name
Duloxetine Zentiva
Aliases
N/ANo risk management plan link.
